Lung
Liquid biopsies and next-generation sequencing have enabled the detection of actionable mutations. Targeted therapies and immunotherapies, such as PD-L1 inhibitors, have transformed treatment outcomes.
Diabetes drug could help cancer patients make better recovery
A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia.
Minimally invasive prostate cancer treatment shows success in first patient
Bill Faulkner had long approached prostate cancer testing with skepticism. For almost a decade, the 73-year-old had avoided the prostate-specific antigen test because of concerns about over-diagnosis; over-treatment; and, most of all, the potentially life-altering side effects of invasive surgical treatments.
Common malaria drug repurposed to fight cancer
Can a drug that’s used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that. Pyronaridine has been used to treat the mosquito-borne infectious disease for over 30 years.
New approach identifies reproducible volatile organic compounds for lung cancer diagnosis
A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in lung cancer cells.
What you can do to limit your risk of cancer
Cancer is the second leading cause of death in the United States. Despite this statistic, local doctors say that there are preventative measures that you can take to lower your risk of being diagnosed.
New cancer vaccine could prevent kidney cancer recurrence
A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery. Researchers at Dana-Farber Cancer Institute tested the vaccine in nine patients with stage III or IV clear cell renal cell carcinoma (a form of kidney cancer).
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard treatments have long-term impacts on their development and quality of life, particularly in small children and infants.
‘Pushing the boundaries of radiation treatment’: Breakthrough in pancreatic cancer therapy advances to clinical trials
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for pancreatic cancer, one of the deadliest cancers with limited therapeutic options.
Study finds stem-like T cells key to lasting immune response in cancer, chronic diseases
Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders—T cells—lose their ability to function effectively. Research, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and the Peter MacCallum Cancer Center (Peter Mac), have identified a rare type of immune cells, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses.
Gene discovery revolutionizes the detection and treatment of prostate cancer
A recent gene discovery has the potential to revolutionize how prostate cancer is detected and treated, offering new hope for patients.
Baptist MD Anderson to launch cellular therapy, stem cell program – The Ponte Vedra Recorder
As part of Baptist Health’s ongoing work to advance cancer care in Northeast Florida and Southeast Georgia, the health system is launching a Stem Cell Transplantation and Cellular Therapy Program …
A simpler, safer treatment for aggressive breast cancer
A simpler, safer treatment for aggressive breast cancer
